Background: Inflammatory bowel disease (IBD) is characterized by chronic
Introduction
Inflammatory bowel disease is characterized by a chronic idiopathic inflammation of the gastrointestinal tract. Despite extensive research and the finding of several factors involved in the pathology of IBD, the aetiology of IBD remains unknown.
Two distinct forms of IBD have been described, Crohn's disease (CD) and ulcerative colitis (UC). The first disease can be present in all of the gastrointestinal tract and both mucosa and smooth muscle can be affected. In this disease ulcerations and transmural inflammation are common and the immune response is dominated by type-1 T-cell activity. On the other hand there is ulcerative colitis, which is mainly characterized by a type-2 immune response and is restricted to the mucosa of the colon and rectum. Clinical features of IBD comprise apart form general manifestations of inflammation a disturbed intestinal and colonic motility, diarrhoea and weight loss [1] . One of the factors that have been proposed to be involved in the pathology of IBD are neuropeptides which are expressed by the dense enteric neuron system in the gastrointestinal tract. Neuropeptides are often involved in the regulation of intestinal motility, fluid secretion and inflammatory processes [2] [3] [4] .
One of these neuropeptides, substance P (SP) is a member of the mammalian tachykinins. Neurokinin A and B (NKA and NKB) are two other members of this family. SP and NKA are derived from the same gene by alternative splicing. There are three different receptors for this peptide family, the NK-1 -2 and -3 receptor with SP, NKA and NKB as its preferred ligands, respectively. All ligands can bind to all receptors [5] . SP and NKA are abundantly expressed in the gastrointestinal tract but NKB much less [6, 7] . The main location of the tachykinins is in the enteric nervous system while they are also present in enteroendocrine and immune cells of the intestinal mucosa. The receptors are expressed by enteric neurones, the muscularis mucosa, interstitial cells of Cajal, longitudinal and circular muscle, epithelium, vasculature and the immune system. All three receptors are present in the intestine but there are differences in distribution and between species. A major action of the tachykinins is their effect on the intestinal motility which can be stimulating and inhibiting depending on the type and place of the receptor that is activated. They are also involved in the secretory function of the intestine by 44 -Chapter three stimulating release of chloride and bicarbonate [6] . Furthermore SP has proinflammatory effects, more precisely it is an important mediator in the neurogenic inflammation. In vitro SP exert chemotactic activity on neutrophils and eosinophils, it further influences cytokines synthesis and release (IL-1, -6, -8 and TNF-Į) and release of histamine from peritoneal mast cells [8, 9] . It has been reported that in the rectum and colon of ulcerative colitis patients the SP levels are increased and correlate with disease activity [10, 11] . Furthermore, in inflammatory bowel disease the NK1 receptors are up regulated in the intestinal blood vessels and lymphoid structure as shown by Mantyh et al. with an emulsion autoradiographic method [12, 13] and by Renzi et al with in situ hybridisation and immunohistochemistry [14] .
Later it was shown that proinflammatory cytokines induce NK1 receptor expression in colonic epithelial cells [15] . Furthermore, NK1 receptor mRNA is elevated in colonic mucosa of IBD patients as compared with non-inflamed control mucosa [16] . With animal models it was shown that NK1 antagonists can reduce the fluid secretion and intestinal inflammation [17] . In most of the above studies one or two techniques are used to describe the NK receptor expression. In this paper we used a combination of three complimentary techniques i.e., quantitative storage phosphor autoradiography, RT-PCR and immunohistochemistry to study the expression of the SP receptor in patients with IBD versus controls.
Material and methods

Tissue samples
Intestinal tissue samples (colon and ileum) were collected at the Leiden University Medical Centre, the Netherlands from 28 patients with IBD (16 CD and 12 UC patients), both from inflamed and non-inflamed areas. Intestinal tissue specimens from patients operated for neoplasm's (n=14) were used as controls. The control tissue was taken at least 10 cm from the affected site. The patients gave consent for the anonymous use of their tissue material. 
Storage phosphor autoradiography
Cryostat tissue sections (14 ȝm) were cut at -20°C, mounted on gelatin-coated glass slides and stored overnight at -80°C. Storage phosphor autoradiography was performed by the following protocol which was optimized in our laboratory. Slides 
Quantitative RT-PCR
The expression of NK-1 mRNA was determined with RT-PCR. Total RNA from the mucosal tissue samples was isolated by phenol chloroform extraction of guanidinium isothiocynate lysates [18] . 
Immunohistochemistry
Immunolocalization of NK-1 receptors was assessed by an indirect peroxidaselabelled antibody method [19] in a subset of 8 control patients and 15 IBD patients.
In brief, paraffin embedded tissue sections (4 ȝm) were cut, mounted on poly-Llysine coated glass slides and dried overnight by 37°C. Tissue was deparafinized and rehydrated. Antigen retrieval was assed by heating the slides for 4 min in the microwave by 450 W and thereafter rinses them in TBS with 0.001% saponin. 
SPR expression in IBD -
47 Slides were incubated for 20 min with 1.5% normal rabbit serum (NRS) to
Data-analysis
Data is expressed as mean ± SEM (standard error of mean). Paired an unpaired
Student's t-test were used to infer significant differences between groups. Values of p < 0.05 were considered significant.
Results
Storage phosphor autoradiography enabled the visualization and quantification of SP binding sites in human intestine. In control patients the amount of binding sites found in the smooth muscle was significantly higher than in the mucosa (17±5 vs 98±20, p=0.01). This was also seen in the tissue of IBD patients although the difference was not significant. For the IBD patients an increase was seen in the amount of binding sites in the mucosa as compared with the control patients. In the non-inflamed mucosal areas of IBD patients there was already an increase but in the inflamed areas this increase was more pronounced and statistically significant 
Discussion
In this paper three different techniques where applied to describe the distribution of the neuropeptide substance P receptor. The first technique, quantitative storage phosphor autoradiography is a method which detects all functional receptors to which SP can bind. The results of this technique are comparable with data reported in literature using film and emulsion autoradiography, but storage phosphor autoradiography has two major advantages over film autoradiography as the
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exposure time is shorter and the dynamic range is larger, which make this technique quantitative over a wide range of receptor amounts. A small disadvantage of storage phosphor autoradiography over the emulsion radiography is the lower resolution [20] . But in case of the human intestine the mucosa can still be measured separately from the smooth muscle, but individual cells in both compartments can not be distinguished. This study showed that in control intestine the most important binding site for SP was the smooth muscle with its enteric nervous system, but also the mucosa expressed SP binding sites. In the inflamed mucosa of IBD patients significant more SP binding sites were expressed as in controls. This finding was in agreement with results from others using film autoradiography [12, 13, 21, 22] . Furthermore we found that this increase was already seen in the non-inflamed tissue of IBD patients (both CD and UC) but to a lower degree.
The second technique used was RT-PCR. The mRNA content of the NK-1 receptor for SP in inflamed IBD mucosa was similar to that in control mucosa and in noninflamed mucosal areas of UC patients. However in CD patients the mRNA content was significantly decreased compared to controls. Goode et al. [16] showed an increase of NK-1 mRNA found in inflamed IBD tissue as compared to controls. The difference between their and our study may be due to difference in study population and collection of tissue. Goode et. al. studied endoscopic specimens for mRNA quantification in contrast to surgical specimen in our study. These investigators used biopsies from active IBD lesions and as controls biopsies from IBD patients without inflammatory activity, while no patient without IBD were studied. As is seen in our study the mRNA content in patients with CD can be decreased in the areas without inflammatory activity. The apparent increase in mRNA in active disease found in their study [16] In this paper the above mentioned three complementary techniques were used for the first time together to study the SP receptor. All three techniques have their own advantages and shortcomings. Combining these three techniques did give a total view of the expression of the neuropeptide SP receptor in the human intestine.
From our study it can be concluded that the SP receptor is broadly expressed in the humane intestine and that SP can have effects both via neurons and directly on the smooth muscle and mucosal cells. In patients with IBD the mucosal SP binding is significantly increased in the inflamed areas, while the mRNA level was not 52 -Chapter three changed. In patients with CD the mRNA content in the non-inflamed areas was decreased while the binding sites already showed a small but not significant increase.
